Home > Offer to Sell > Pharmaceuticals and Biochemicals > Hormones and synthetic substitutes > daclatasvir
daclatasvir
Inquiry
Post Date: | Dec 15,2023 |
Expiry Date: | Jun 12,2024 |
Detailed Description: |
Cas No. :1009119-64-5
Quantity: 100Kilograms Specs:In-house standard,DMF and CEP available Payment Method: T/T in advance L/C White powder,In-house powder,DMF available. |
CAS Registry Number: | 1009119-64-5 |
Synonyms: | ;Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, dimethyl ester;dimethyl (2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-(biphenyl-4,4'-diyl)bis(1H-imidazole-4,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate;Methyl [(2S)-1-{(2S)-2-[5-(4'-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-pyrrolidinyl]-1H-imidazol-5-yl}-4-biphenylyl)-1H-imidazol-2-yl]-1-pyrrolidinyl}-3-methyl-1-oxo-2-butanyl]c arbamate;Daclatasvir; |
Molecular Formula: | C40H50N8O6 |
Molecular Weight: | 738.88 |
Molecular Structure: |
Company: | Hangzhou Maytime Bio-Tech Co.,Ltd. (Starview International Limited) [ China ] |
Contact: | Leo Tong |
Tel: | +86-571-88925295,88920965 |
Fax: | +86-571-88218645 |
Email: | sales@maytime.com.cn |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.